HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-64945-3
Affiliations:
9
Authors:
21
Go to article
Institutions Authors Share
University of Oxford, United Kingdom (UK)
8.000000
 0.38
Charité - University Medicine Berlin, Germany
6.333333
 0.30
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Germany
5.500000
 0.26
Center for Cell and Gene Therapy (CAGT), United States of America (USA)
0.500000
 0.02
DKTK Partner Site Berlin, Germany
0.333333
 0.02
Baylor College of Medicine (BCM), United States of America (USA)
0.166667
 0.01
Dan L. Duncan Comprehensive Cancer Center, United States of America (USA)
0.166667
 0.01
Interested in Agricultural Biotechnology?